Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Lyell Immunopharma IncCommon Stock stock

Learn how to easily invest in Lyell Immunopharma IncCommon Stock stock.

Lyell Immunopharma Inc. Common Stock is a biotechnology business based in the US. Lyell Immunopharma IncCommon Stock shares (LYEL) are listed on the NASDAQ and all prices are listed in US Dollars. Lyell Immunopharma IncCommon Stock employs 188 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Lyell Immunopharma IncCommon Stock

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LYEL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Lyell Immunopharma IncCommon Stock stock price (NASDAQ: LYEL)

Use our graph to track the performance of LYEL stocks over time.

Lyell Immunopharma IncCommon Stock shares at a glance

Information last updated 2022-01-26.
Latest market close$5.44
52-week range$4.95 - $19.84
50-day moving average $8.33
200-day moving average $12.61
Wall St. target price$23.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.59

Buy Lyell Immunopharma IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Lyell Immunopharma IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lyell Immunopharma IncCommon Stock price performance over time

Historical closes compared with the close of $5.44 from 2022-01-26

1 week (2022-01-20) -1.27%
1 month (2021-12-27) -29.26%
3 months (2021-10-27) -62.14%
6 months (2021-07-27) -62.25%
1 year (2021-01-23) N/A
2 years (2020-01-23) N/A
3 years (2019-01-23) N/A
5 years (2017-01-23) N/A

Lyell Immunopharma IncCommon Stock financials

Revenue TTM $10.1 million
Gross profit TTM $7.8 million
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $4.11
Market capitalisation $1.3 billion

TTM: trailing 12 months

Lyell Immunopharma IncCommon Stock share dividends

We're not expecting Lyell Immunopharma IncCommon Stock to pay a dividend over the next 12 months.

Lyell Immunopharma IncCommon Stock overview

Lyell Immunopharma, Inc. , a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845 for multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California. .

Frequently asked questions

What percentage of Lyell Immunopharma IncCommon Stock is owned by insiders or institutions?
Currently 16.163% of Lyell Immunopharma IncCommon Stock shares are held by insiders and 32.559% by institutions.
How many people work for Lyell Immunopharma IncCommon Stock?
Latest data suggests 188 work at Lyell Immunopharma IncCommon Stock.
When does the fiscal year end for Lyell Immunopharma IncCommon Stock?
Lyell Immunopharma IncCommon Stock's fiscal year ends in December.
Where is Lyell Immunopharma IncCommon Stock based?
Lyell Immunopharma IncCommon Stock's address is: 400 East Jamie Court, South San Francisco, CA, United States, 94080
What is Lyell Immunopharma IncCommon Stock's ISIN number?
Lyell Immunopharma IncCommon Stock's international securities identification number is: US55083R1041

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site